Friedreich's Ataxia

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

Lexeo plans to combine pooled study data with a forthcoming pivotal trial in a submission focused on treating cardiomyopathy.